Latest news

Gainers Turning Point Therapeutics, Inc. (NASDAQ: TPTX) shares climbed 118.4% to close at $74.59 on Friday after Bristol Myers Squibb announced it will acquire Turning Point Therapeutics for $76 per share.

 

Gainers Adaptimmune Therapeutics (NASDAQ:ADAP) stock rose 12.7% to $1.6 during Monday's after-market session. The market value of their outstanding shares is at $258.9 million.

  On Wednesday, 807 companies reached new 52-week lows.

SVB Leerink analyst Jonathan Chang maintains Adaptimmune Therapeutics (NASDAQ:ADAP) with a Market Perform and raises the price target from $2 to $3.

  Companies Reporting Before The Bell • Atlantica Sustainable (NASDAQ:AY) is likely to report quarterly loss at $0.08 per share on revenue of $277.90 million.

  On Friday, 1043 companies hit new 52-week lows.

  Adaptimmune Therapeutics (NASDAQ:ADAP) will host a conference call at 08:00 AM ET on May 9, 2022, to discuss Q1 2022 earnings results.

  During Thursday, 849 stocks hit new 52-week lows.

-Reuters